ManTech International Corp
Change company Symbol lookup
Select an option...
MANT ManTech International Corp
AMPE Ampio Pharmaceuticals Inc
MA Mastercard Inc
RJF Raymond James Financial Inc
PACW PacWest Bancorp
MAPS WM Technology Inc
AR Antero Resources Corp
PAYX Paychex Inc
AEHL Antelope Enterprise Holdings Ltd
NOV Nov Inc
Go

Industrials : Professional Services | Small Cap Value
Company profile

ManTech International Corporation is a provider of technology solutions and services for the United States intelligence community, defence and federal civilian agencies. The Company is engaged in offering a spectrum cyber, data collection and analytics, enterprise information technology (IT) and systems engineering and software application development solutions that supports national and homeland security. It provides services and solutions that support missions of national priority, such as global cyber operations, military operational readiness, information technology (IT) and digital modernization, and national security threat intelligence and analytics. It focuses on cyber network operations, defence, analytics, hardening and resilience, security orchestration, automation and response, range and training, and risk management and compliance. It also provides model-based systems engineering, predictive analytics, data/computational science, and cloud engineering solutions.

Closing Price
$73.52
Day's Change
0.32 (0.44%)
Bid
--
Ask
--
B/A Size
--
Day's High
73.83
Day's Low
72.30
Volume
(Heavy Day)
Volume:
186,988

10-day average volume:
140,882
186,988

Regeneron Announces Investor Conference Presentations

4:15 pm ET November 16, 2021 (PR Newswire) Print

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows:

-- Evercore ISI 4th Annual HealthCONx Conference at 9:15 a.m. ET on Tuesday, November 30, 2021

-- Piper Sandler 33rd Annual Healthcare Conference at 8:00 a.m. ET on Wednesday, December 1, 2021

The sessions may be accessed from the "Investors & Media" page of Regeneron's website at https://investor.regeneron.com/events-and-presentations. Replays of the webcasts will be archived on the Company's website for at least 30 days.

About RegeneronRegeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic conditions, infectious diseases and rare diseases.

Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite(R) technologies, such as VelocImmune(R), which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.

For additional information about the company, please visit www.regeneron.com or follow @Regeneron on Twitter.

Contact Information:Investor RelationsMark Hudson 914.847.3482 mark.hudson@regeneron.com

https://c212.net/c/img/favicon.png?sn=NY78431&sd=2021-11-16

View original content:https://www.prnewswire.com/news-releases/regeneron-announces-investor-conference-presentations-301425884.html

SOURCE Regeneron Pharmaceuticals, Inc.

https://rt.prnewswire.com/rt.gif?NewsItemId=NY78431&Transmission_Id=202111161615PR_NEWS_USPR_____NY78431&DateId=20211116

comtex tracking

COMTEX_397066840/1005/2021-11-16T16:15:04

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.